Pharmaceutical Technology1mon
Bio-Thera signs US deal with Intas for golimumab biosimilar
Accord BioPharma US president Chrys Kokino stated: “Our exclusive commercialisation agreement with Bio-Thera strengthens our biosimilar pipeline, a vital component of our US growth strategy. “We’re ...
Yahoo Finance1mon
Accord BioPharma Strengthens Pipeline Through Exclusive U.S. Licensing Agreement with Bio-Thera for BAT2506, a Proposed Golimumab Biosimilar
"Our U.S. portfolio of biosimilars continues to rapidly expand at multiple levels across the drug development and commercialization cycle," said Chrys Kokino, U.S. President of Accord. "In ...
Contract Pharma1mon
Accord, Bio-Thera Partner on Simponi Biosimilar BAT2506
“Our U.S. portfolio of biosimilars continues to rapidly expand at multiple levels across the drug development and commercialization cycle,” said Chrys Kokino, U.S. President of Accord. “In addition to ...
BioSpace1mon
Accord BioPharma Strengthens Pipeline Through Exclusive U.S. Licensing Agreement with Bio-Thera for BAT2506, a Proposed Golimumab Biosimilar
“Our U.S. portfolio of biosimilars continues to rapidly expand at multiple levels across the drug development and commercialization cycle,” said Chrys Kokino, U.S. President of Accord. “In addition to ...